Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- TFPM +6.7% (Q3 revs and production), DPZ +2.4%, TLRY +0.6%, NEOG +0.5%
Other news:
- TPST +33% (announces agreement with Roche (RHHBY) to support advancement of Amezalpat combination therapy into first-line hepatocellular carcinoma pivotal trial)
- EXAI +5.8% (Exscientia plc and Recursion Pharmaceuticals (RXRX) file definitive joint proxy statement in connection with shareholder meetings on November 12)
- AVNT +5% (raises annual dividend by 5%)
- MGTX +3.4% (announces poster presentation on MC4R Genetic Deficiency)
- SYM +2.5% (has entered into commercial agreements with Walmart de México y Centroamérica to implement Symbotic's industry-leading warehouse automation systems in two of the retailer's locations near Mexico City)
- BWLP +2.1% (provides update on co's Product Services Q3 segment performance)
- GEL +2.1% (increases common stock distribution to $0.165/share from $0.15/share)
- MPTI +1.6% (names new CFO, also provides guidance)
- CNM +1.3% (to acquire Eastcom Associates; also to acquire ARGCO Northeast)
- TSLA +1.2% (expected to unveil its RoboTaxi at an event at 9 PM ET tonight)